Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer

International Journal of Cancer

Volumn 128, Issue 3, 2011, Pages 541-550

  Kawakami, Kazumori ^a   Yamamura, Soichiro ^a   Hirata, Hiroshi ^a   Ueno, Koji ^a   Saini, Sharanjot ^a   Majid, Shahana ^a   Tanaka, Yuichiro ^a   Kawamoto, Ken ^b   Enokida, Hideki ^b   Nakagawa, Masayuki ^b   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

histone modification; methylation; RCC; sFRP 5; tumor suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; GENOMIC DNA; HISTONE H3; HISTONE H4; SECRETED FRIZZLED RELATED PROTEIN 5;

ACETYLATION; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL ANCHORAGE; CELL INVASION; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DNA METHYLATION; DNA PRIMERS; DOWN-REGULATION; FRIZZLED RECEPTORS; HISTONES; HUMANS; KIDNEY; KIDNEY NEOPLASMS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 78649872309     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25357     Document Type: Article

References (43)

1. Guillén-Ahlers H,. Wnt signaling in renal cancer. Curr Drug Targets 2008; 9: 591-600.
2. Cadigan KM, Nusse R,. Wnt signaling: a common theme in animal development. Genes Dev 1997; 11: 3286-305.
3. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W,. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-42.
4. Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J, Wang CY,. Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription. J Cell Biol 2001; 152: 87-96.
5. Veeck J, Geisler C, Noetzel E, Alkaya S, Hartmann A, Knüchel R, Dahl E,. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. Carcinogenesis 2008; 29: 991-8.
6. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW,. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275: 1787-90.
7. Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM,. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003; 22: 7218-21.
8. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, et al. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway. Clin Cancer Res 2006; 12: 383-91.
9. Heller RS, Dichmann DS, Jensen J, Miller C, Wong G, Madsen OD, Serup P,. Expression patterns of Wnts. Frizzleds, s. FRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation. Dev Dyn 2002; 225: 260-70.
10. Kawano Y, Kypta R,. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003; 116: 2627-34.
11. Huang HC, Klein PS,. The Frizzled family: receptors for multiple signal transduction pathways. Genome Biol 2004; 5: 234.
12. Hellebrekers DM, Griffioen AW, van Engeland M,. Dual targeting of epigenetic therapy in cancer. Biochim Biophys Acta 2007; 1775: 76-91.
13. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R,. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009; 30: 662-70.
14. Morris MR, Gentle D, Abdulrahman M, et al. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Br J Cancer 2008; 98: 496-501.
15. Reu FJ, Leaman DW, Maitra RR, Bae SI, Cherkassky L, Fox MW, Rempinski DR, Beaulieu N, MacLeod AR, Borden EC,. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons. Cancer Res 2006; 66: 2785-93.
16. Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O,. Methylation-associated silencing of SFRP1 in renal cell carcinoma. Oncol Rep 2008; 20: 1257-63.
17. Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, Sun LZ, Ahlquist DA, et al. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 2007; 13: 4740-9.
18. Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, et al. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene 2007; 26: 5680-91.
19. Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R,. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer 2008; 123: 535-42.
20. Zhao C, Bu X, Zhang N, Wang W,. Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer. BMC Cancer 2009; 9: 224.
21. Lin YW, Chung MT, Lai HC, De Yan M, Shih YL, Chang CC, Yu MH,. Methylation analysis of SFRP genes family in cervical adenocarcinoma. J Cancer Res Clin Oncol 2009; 135: 1665-74.
22. Chung MT, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Chu TY, Lai HC, Lin YW,. Promoter methylation of SFRPs gene family in cervical cancer. Gynecol Oncol 2009; 112: 301-6.
23. Takagi H, Sasaki S, Suzuki H, Toyota M, Maruyama R, Nojima M, Yamamoto H, Omata M, Tokino T, Imai K, Shinomura Y,. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol 2008; 43: 378-89.
24. Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA,. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer 2005; 116: 584-91.
25. Sogabe Y, Suzuki H, Toyota M, Ogi K, Imai T, Nojima M, Sasaki Y, Hiratsuka H, Tokino T,. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. Int J Oncol 2008; 32: 1253-61.
26. Suzuki H, Toyota M, Carraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, Mori M, Hirata K, et al. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 2008; 98: 1147-56.
27. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36: 417-22.
28. Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R,. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 2006; 12: 2109-16.
29. Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R,. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res 2006; 12: 6989-97.
30. Li LC, Dahiya R,. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-31.
31. Gavin DP, Kartan S, Chase K, Jayaraman S, Sharma RP,. Histone deacetylase inhibitors and candidate gene expression: an in vivo and in vitro approach to studying chromatin remodeling in a clinical population. J Psychiatr Res 2009; 43: 870-6.
32. Garcia JA, Cowey CL, Godley PA,. Renal cell carcinoma. Curr Opin Oncol 2009; 21: 266-71.
33. Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA,. Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells. Oncogene 2001; 20: 7787-96.
34. Nakagawachi T, Soejima H, Urano T, Zhao W, Higashimoto K, Satoh Y, Matsukura S, Kudo S, Kitajima Y, Harada H, Furukawa K, Matsuzaki H, et al. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene 2003; 22: 8835-44.
35. Zhang Z, Joh K, Yatsuki H, Zhao W, Soejima H, Higashimoto K, Noguchi M, Yokoyama M, Iwasaka T, Mukai T,. Retinoic acid receptor β2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells. Cancer Lett 2007; 247: 318-27.
36. Baylin SB, Höppener JW, de Bustros A, Steenbergh PH, Lips CJ, Nelkin BD,. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res 1986; 46: 2917-22.
37. Kondo Y, Shen L, Issa JP,. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 2003; 23: 206-15.
38. Shi Y, He B, You L, Jablons DM,. Roles of secreted frizzled-related proteins in cancer. Acta Pharmacol Sin 2007; 28: 1499-504.
39. Dehner M, Hadjihannas M, Weiske J, Huber O, Behrens J,. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1. J Biol Chem 2008; 283: 19201-10.
40. Tapia JC, Torres VA, Rodriguez DA, Leyton L, Quest AF,. Casein kinase 2 (CK2) increases survivin expression via enhanced β-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc Natl Acad Sci USA 2006; 103: 15079-84.
41. Han QF, Zhao W, Bentel J, Shearwood AM, Zeps N, Joseph D, Iacopetta B, Dharmarajan A,. Expression of sFRP-4 and β-catenin in human colorectal carcinoma. Cancer Lett 2006; 231: 129-37.
42. Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, Weller M,. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 2000; 19: 4210-20.
43. Han X, Amar S,. Secreted frizzled-related protein 1 (SFRP1) protects fibroblasts from ceramide-induced apoptosis. J Biol Chem 2004; 279: 2832-40.